MIMETAS, the market leader in Organ-on-a-chip products, announced that the National Cancer Institute recently awarded them a phase 1 SBIR grant totally $300,000 to develop personalized prostate cancer-on-a-chip models that can more accurately reproduce the tumor micro-environment. MIMETAS has built a consortium with the University of Texas Health Science Center (UTHSC) and MD Anderson to build the next generation platform for cancer drug screening and personal therapy prediction.
{iframe}https://mimetas.com/mimetas-news/nci-sbir-grant-personalized-cancer-chip?utm_source=MIMETAS+-+The+Organ-on-a-Chip+Company&utm_campaign=b32a36c4f8-MIMETAS_Newsletter&utm_medium=email&utm_term=0_d0a2ab9bf5-b32a36c4f8-446883869&mc_cid=b32a36c4f8&mc_eid=58aba33cb8{/iframe}